The translocator protein ligands as mitochondrial functional modulators for the potential anti-Alzheimer agents

References

• Anand R, Gill KD, Mahdi AA. Therapeutics of Alzheimer’s disease: past, present and future. Neuropharmacology 2014;76:27–50.
   PubMed Web of Science ®Google Scholar
• Kumar A, Singh A. Ekavali. A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacol Rep 2015;67:195–203.
   PubMed Web of Science ®Google Scholar
• Tanzi RE, Bertram L. Twenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspective. Cell 2005;120:545–55.
   PubMed Web of Science ®Google Scholar
• LaFerla FM, Green KN, Oddo S. Intracellular amyloid-beta in Alzheimer’s disease. Nat Rev Neurosci 2007;8:499–509.
   PubMed Web of Science ®Google Scholar
• Readnower RD, Sauerbeck AD, Sullivan PG. Mitochondria, amyloid beta, and Alzheimer’s disease. Int J Alzheimers Dis 2011;2011:1–5.
   Google Scholar
• Eckert GP, Renner K, Eckert SH, et al. Mitochondrial dysfunction-a pharmacological target in Alzheimer’s disease. Mol Neurobiol 2012;46:136–50.
   PubMed Web of Science ®Google Scholar
• Santos RX, Correia SC, Wang X, et al. Alzheimer’s disease: diverse aspects of mitochondrial malfunctioning. Int J Clin Exp Pathol 2010;3:570–81.
   PubMed Web of Science ®Google Scholar
• Moreira PI, Carvalho C, Zhu X, et al. Mitochondrial dysfunction is a trigger of Alzheimer’s disease pathophysiology. Biochim Biophys Acta 2010;1802:2–10.
   PubMed Web of Science ®Google Scholar
• Chua SW, Kassiou M, Ittner LM. The translocator protein as a drug target in Alzheimer’s disease. Expert Rev Neurother 2014;14:439–48.
   PubMed Web of Science ®Google Scholar
• Papadopoulos V, Baraldi M, Guilarte TR, et al. Translocator protein (18kda): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 2006;27:402–9.
   PubMed Web of Science ®Google Scholar
• Veenman L, Gavish M. The role of 18 kda mitochondrial translocator protein (tspo) in programmed cell death, and effects of steroids on tspo expression. Curr Mol Med 2012;12:398–412.
   PubMed Web of Science ®Google Scholar
• Leaver KR, Reynolds A, Bodard S, et al. Effects of translocator protein (18 kda) ligands on microglial activation and neuronal death in the quinolinic-acid-injected rat striatum. ACS Chem Neurosci 2012;3:114–9.
   PubMed Web of Science ®Google Scholar
• Starkov AA, Beal FM. Portal to Alzheimer’s disease. Nat Med 2008;14:1020–1.
   PubMed Web of Science ®Google Scholar
• Rupprecht R, Papadopoulos V, Rammes G, et al. Translocator protein (18 kda) (tspo) as a therapeutic target for neurological and psychiatric disorders. Nature Rev Drug Discov 2010;9:971–88.
   PubMed Web of Science ®Google Scholar
• Du H, Guo L, Fang F, et al. Cyclophilin d deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer’s disease. Nat Med 2008;14:1097–105.
   PubMed Web of Science ®Google Scholar
• Du H, Yan SS. Mitochondrial permeability transition pore in Alzheimer’s disease: cyclophilin d and amyloid beta. Biochim Biophys Acta 2010;1802:198–204.
   PubMed Web of Science ®Google Scholar
• Chelli B, Falleni A, Salvetti F, et al. Peripheral-type benzodiazepine receptor ligands: mitochondrial permeability transition induction in rat cardiac tissue. Biochem Pharmacol 2001;61:695–705.
   PubMed Web of Science ®Google Scholar
• Krestinina OV, Grachev DE, Odinokova IV, et al. Effect of peripheral benzodiazepine receptor (pbr/tspo) ligands on opening of ca2+-induced pore and phosphorylation of 3.5-kda polypeptide in rat brain mitochondria. Biochemistry (Mosc) 2009;74:421–9.
   PubMed Web of Science ®Google Scholar
• Kim YS, Jung SH, Park BG, et al. Synthesis and evaluation of oxime derivatives as modulators for amyloid beta-induced mitochondrial dysfunction. Eur J Med Chem 2013;62:71–83.
   PubMed Web of Science ®Google Scholar
• Barron AM, Garcia-Segura LM, Caruso D, et al. Ligand for translocator protein reverses pathology in a mouse model of Alzheimer’s disease. J Neurosci 2013;33:8891–7.
   PubMed Web of Science ®Google Scholar
• Gatliff J, East D, Crosby J, et al. Tspo interacts with vdac1 and triggers a ROS-mediated inhibition of mitochondrial quality control. Autophagy 2014;10:2279–96.
   PubMed Web of Science ®Google Scholar
• Werry EL, Bright FM, Piguet O, et al. Recent developments in tspo pet imaging as a biomarker of neuroinflammation in neurodegenerative disorders. Int J Mol Sci 2019;20:3161.
   Web of Science ®Google Scholar
• Barresi E, Robello M, Costa B, et al. An update into the medicinal chemistry of translocator protein (tspo) ligands. Eur J Med Chem 2021;209:112924.
   PubMed Web of Science ®Google Scholar
• Venneti S, Wang G, Wiley CA. The high affinity peripheral benzodiazepine receptor ligand daa1106 binds to activated and infected brain macrophages in areas of synaptic degeneration: implications for pet imaging of neuroinflammation in lentiviral encephalitis. Neurobiol Dis 2008;29:232–41.
   PubMed Web of Science ®Google Scholar
• Chen MK, Guilarte TR. Translocator protein 18 kda (tspo): molecular sensor of brain injury and repair. Pharmacol Ther 2008;118:1–17.
   PubMed Web of Science ®Google Scholar
• Li F, Liu J, Zheng Y, et al. Crystal structures of translocator protein (tspo) and mutant mimic of a human polymorphism. Science 2015;347:555–8.
   PubMed Web of Science ®Google Scholar
• Guo YZ, Kalathur RC, Liu Q, et al. Protein structure. Structure and activity of tryptophan-rich TSPO proteins . Science 2015;347:551–5.
   PubMed Web of Science ®Google Scholar
• Cho SM, Kim HV, Lee S, et al. Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model. Sci Rep 2014;4:6777.
   PubMed Web of Science ®Google Scholar
• Kozikowski AP, Ma D, Brewer J, et al. Chemistry, binding affinities, and behavioral properties of a new class of “antineophobic” mitochondrial dbi receptor complex (mdrc) ligands. J Med Chem 1993;36:2908–20.
   PubMed Web of Science ®Google Scholar
• Trapani G, Laquintana V, Denora N, et al. Structure-activity relationships and effects on neuroactive steroid synthesis in a series of 2-phenylimidazo[1,2-a]pyridineacetamide peripheral benzodiazepine receptors ligands. J Med Chem 2005;48:292–305.
   PubMed Web of Science ®Google Scholar
• Okuyama S, Chaki S, Yoshikawa R, et al. Neuropharmacological profile of peripheral benzodiazepine receptor agonists, daa1097 and daa1106. Life Sci 1999;64:1455–64.
   PubMed Web of Science ®Google Scholar
• Das SK, Sikpi MO, Skolnick P. Characterization of [3h]ro5-4864 binding to “peripheral” benzodiazepine receptors in guinea pig alveolar type ii cells. Biochem Pharmacol 1987;36:2221–4.
   PubMed Web of Science ®Google Scholar
• Rosenberg N, Rosenberg O, Weizman A, et al. In vitro mitochondrial effects of pk 11195, a synthetic translocator protein 18 kDa (TSPO) ligand, in human osteoblast-like cells. J Bioenerg Biomembr 2011;43:739–46.
   PubMed Web of Science ®Google Scholar
• Adane L, Bharatam PV, Sharma V. A common feature-based 3d-pharmacophore model generation and virtual screening: identification of potential pfdhfr inhibitors. J Enzyme Inhib Med Chem 2010;25:635–45.
   PubMed Web of Science ®Google Scholar
• Xing RJ, Wang J, Pan L, Cheng MS. A selective pharmacophore model for beta(2)-adrenoceptor agonists. Molecules 2009;14:4486–96.
   PubMed Web of Science ®Google Scholar
• Kurz C, Ungerer I, Lipka U, et al. The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by beta-amyloid peptide. Br J Pharmacol 2010;160:246–57.
   PubMed Web of Science ®Google Scholar
• Halestrap AP, Pasdois P. The role of the mitochondrial permeability transition pore in heart disease. Biochim Biophys Acta 2009;1787:1402–15.
   PubMed Web of Science ®Google Scholar
• Riedel G, Wetzel W, Reymann KG. Computer-assisted shock-reinforced y-maze training: a method for studying spatial alternation behaviour. Neuroreport 1994;5:2061–4.
   PubMed Web of Science ®Google Scholar
• Oddo S, Caccamo A, Shepherd JD, et al. Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003;39:409–21.
   PubMed Web of Science ®Google Scholar
• Fanselow MS, Poulos AM. The neuroscience of mammalian associative learning. Annu Rev Psychol 2005;56:207–34.
   PubMed Web of Science ®Google Scholar
• Abaee MS, Cheraghi S. Efficient three-component gewald reactions under et3n/h2o conditions. J Sulfur Chem 2014;35:261–9.
   Web of Science ®Google Scholar
• Kim S, Yi KY. 1, 1'-thiocarbonyldi-2, 2'-pyridone. A new useful reagent for functional group conversions under essentially neutral conditions. J Organic Chem 1986;51:2613–5.
   Web of Science ®Google Scholar
• Shi Y, Sitkoff D, Zhang J, et al. Design, structure-activity relationships, x-ray crystal structure, and energetic contributions of a critical p1 pharmacophore: 3-chloroindole-7-yl-based factor xa inhibitors. J Med Chem 2008;51:7541–51.
   PubMed Web of Science ®Google Scholar
• Ahmed EK. Synthesis of some new pyrido [4′, 3′: 4, 5] thieno [2, 3-d] pyrimidines and related fused heterocycles. Phosphorus Sulfur Silicon Relat Elem 2003;178:1–16.
   Web of Science ®Google Scholar